Results 191 to 200 of about 8,375,026 (338)
Characterization of human antibody-reactive epitopes encoded by human papillomavirus types 16 and 18 [PDF]
Steven Jenison+3 more
openalex +1 more source
Opportunities and challenges for human papillomavirus vaccination in cancer
R. Roden, P. Stern
semanticscholar +1 more source
Improving imiquimod use in cervical high‐grade squamous intraepithelial lesions: A qualitative study
Adequate patient counselling on imiquimod treatment, including the possible application methods and potential side effects, along with optimal guidance during treatment, contributes to a better patient experience and reduces the likelihood of early discontinuation of treatment.
Caroline L. P. Muntinga+9 more
wiley +1 more source
De-escalation of radiotherapy in the treatment of human papillomavirus-associated oropharyngeal cancer. [PDF]
Lawless AK+5 more
europepmc +1 more source
European federation for colposcopy calls for ethical evidence‐based practices on adjuvant HPV vaccination. Large appropriately powered RCTs are needed to show effectiveness of vaccination before vaccination can be largely recommended to patients. Abstract Introduction Patients treated for cervical precancerous lesions have a long‐term increased risk ...
Annu Heinonen+6 more
wiley +1 more source
Correction: A scoping review of human papillomavirus related data system in China. [PDF]
Li Y+6 more
europepmc +1 more source
Anti‐PF4 disorders: Pathogenesis, diagnosis and treatment
Anti‐platelet factor 4 (PF4) disorders include heparin‐induced thrombocytopenia (HIT) and vaccine‐induced immune thrombocytopenia and thrombosis (VITT)/VITT‐like disorders. The formation of immunoglobulin G (IgG)/PF4 immune complexes facilitates uncontrolled activation of platelets, neutrophils and monocytes via IgG‐mediated Fcγ receptor binding.
Megan V. Preece+3 more
wiley +1 more source
A Review of Human Papillomavirus Prevalence and Cervical Cancer in Myanmar. [PDF]
Win TZK+7 more
europepmc +1 more source